Total Funding
10
Total FundingSeries D raised
Growth Score
pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
374456
Sequent Medical develops innovative catheter-based technologies for the treatment of neurovascular diseases.
Melanie Parravi: VP of Quality Assurance & Regulatory CompliancePast Role: MicroTherapeutics, Director of Quality Systems- Amy L. Walters: VP of Clinical & Regulatory AffairsPast Role: Biosense Webster, Director of Clinical and Regulatory
About the Company
Founded in 2007, Sequent Medical, Inc. is a privately-held venture backed medical device company dedicated to the development of innovative catheter-based neurovascular technologies. The company has invented and developed the proprietary Microbraid™ technology to create the WEB™ Aneurysm Embolization System, a compelling and versatile new option
for the treatment of both ruptured and unruptured aneurysms. The WEB has received the CE mark and to date has been used to treat a wide variety of nearly 600 aneurysms in Europe, Latin America and New Zealand. The WEB is not available for sale or use in the United States.
Sequent Medical, Inc. is headquartered in Aliso Viejo, California and has European operations based in Bonn, Germany.
